DEA

Another year has come and gone, and cannabis still remains federally illegal. Here's the good, the bad, and the ugly in drug reform this year.

The Japanese parliament approves legislation allowing for medical use but criminalizing recreational use of marijuana, a bipartisan bill to mandate that hospitals test for the presence of fentanyl is introduced, and more.

President Biden remains steadfast in his opposition to federal marijuana legalization, Ohio's Republican governor calls for the legislature to amend the brand new marijuana legalization initiative before it goes into effect next month, and more.

A New York assemblyman wants to ban marijuana billboards, Utah medical marijuana dispensary workers vote to unionize, and more.

Arizona pot shop social equity licenses are having a hard time getting their doors open, Kentucky's governor signs an executive order creating a medical marijuana working group, and more.

A pair of Republican senators file a bill to require congressional approval to down-schedule marijuana, the House Rules Committee advances a pair of psychedelic research amendments to the defense spending bill, and more.

Republican presidential contenders burnish their anti-drug reform credentials, and more.

The White House rolls out a National Response Plan for the emerging threat of fentanyl combined with xylazine.

A federal bill to fund university research on medical maerijuana gets filed, a federal asset forfeiture reform bill moves, and more.

The Louisiana House votes to radically quicken expungements for pot possession offenses, a Texas medical marijuana bill is dead in the water in the state Senate, and more.